Concepts (106)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Semen | 2 | 2020 | 550 | 1.13 | Why? |
| Candidemia | 1 | 2021 | 353 | 0.64 | Why? |
| Administrative Personnel | 1 | 2020 | 326 | 0.64 | Why? |
| Guanine | 1 | 2017 | 146 | 0.64 | Why? |
| Tenofovir | 1 | 2017 | 449 | 0.52 | Why? |
| Antifungal Agents | 1 | 2021 | 1828 | 0.42 | Why? |
| Hepatitis B, Chronic | 1 | 2017 | 616 | 0.41 | Why? |
| Turkey | 6 | 2021 | 3937 | 0.37 | Why? |
| International Cooperation | 1 | 2020 | 3436 | 0.31 | Why? |
| Mortality | 2 | 2021 | 7132 | 0.28 | Why? |
| Sulfhydryl Compounds | 1 | 2021 | 104 | 0.20 | Why? |
| Disulfides | 1 | 2021 | 161 | 0.20 | Why? |
| Superinfection | 1 | 2021 | 459 | 0.16 | Why? |
| Sustained Virologic Response | 1 | 2018 | 378 | 0.16 | Why? |
| Weight Loss | 1 | 2021 | 826 | 0.15 | Why? |
| Myalgia | 1 | 2021 | 1015 | 0.15 | Why? |
| Nucleosides | 1 | 2017 | 221 | 0.14 | Why? |
| Ventricular Dysfunction, Right | 1 | 2021 | 639 | 0.13 | Why? |
| Endocarditis, Bacterial | 1 | 2019 | 344 | 0.13 | Why? |
| Gram-Negative Bacterial Infections | 1 | 2019 | 398 | 0.13 | Why? |
| False Negative Reactions | 1 | 2020 | 1785 | 0.13 | Why? |
| RNA, Viral | 2 | 2020 | 32276 | 0.13 | Why? |
| Pyrazines | 2 | 2021 | 1783 | 0.12 | Why? |
| Nasopharynx | 3 | 2020 | 10224 | 0.12 | Why? |
| Amides | 2 | 2021 | 1864 | 0.12 | Why? |
| Acinetobacter baumannii | 1 | 2016 | 378 | 0.12 | Why? |
| Ivermectin | 1 | 2021 | 973 | 0.11 | Why? |
| Antiviral Agents | 3 | 2021 | 41703 | 0.11 | Why? |
| Fatigue | 1 | 2021 | 2479 | 0.10 | Why? |
| Patient Compliance | 1 | 2020 | 1468 | 0.10 | Why? |
| Middle Aged | 13 | 2021 | 270681 | 0.10 | Why? |
| Prospective Studies | 4 | 2021 | 43301 | 0.09 | Why? |
| Retrospective Studies | 8 | 2021 | 105322 | 0.09 | Why? |
| Hepatitis C, Chronic | 1 | 2018 | 973 | 0.09 | Why? |
| Adult | 10 | 2021 | 244371 | 0.09 | Why? |
| Asymptomatic Diseases | 1 | 2020 | 3444 | 0.09 | Why? |
| Aged, 80 and over | 5 | 2021 | 88759 | 0.08 | Why? |
| Adolescent | 5 | 2021 | 86841 | 0.08 | Why? |
| World Health Organization | 1 | 2020 | 4213 | 0.08 | Why? |
| Young Adult | 5 | 2021 | 93724 | 0.08 | Why? |
| Symptom Assessment | 1 | 2020 | 4967 | 0.08 | Why? |
| Intensive Care Units | 3 | 2021 | 29594 | 0.08 | Why? |
| Time Factors | 2 | 2020 | 31397 | 0.07 | Why? |
| Humans | 20 | 2021 | 930598 | 0.07 | Why? |
| Pneumonia, Viral | 4 | 2021 | 243684 | 0.07 | Why? |
| Risk Factors | 4 | 2021 | 71621 | 0.07 | Why? |
| Universities | 1 | 2020 | 4374 | 0.07 | Why? |
| Aged | 8 | 2021 | 215776 | 0.07 | Why? |
| Transplant Recipients | 1 | 2020 | 4982 | 0.07 | Why? |
| Immunocompromised Host | 1 | 2020 | 5150 | 0.06 | Why? |
| Interleukin-6 | 1 | 2021 | 7522 | 0.06 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.06 | Why? |
| Male | 11 | 2021 | 367725 | 0.06 | Why? |
| Specimen Handling | 1 | 2020 | 6190 | 0.06 | Why? |
| Prevalence | 2 | 2021 | 25773 | 0.06 | Why? |
| Cytochrome P-450 CYP3A | 1 | 2021 | 88 | 0.05 | Why? |
| Coinfection | 1 | 2021 | 6820 | 0.05 | Why? |
| Hospitalization | 3 | 2021 | 54280 | 0.05 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2020 | 11367 | 0.05 | Why? |
| Cohort Studies | 3 | 2021 | 36005 | 0.05 | Why? |
| Pandemics | 4 | 2020 | 389249 | 0.05 | Why? |
| Hydroxychloroquine | 2 | 2021 | 12447 | 0.05 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.05 | Why? |
| Viral Load | 1 | 2020 | 15850 | 0.05 | Why? |
| Female | 10 | 2021 | 380317 | 0.05 | Why? |
| Echocardiography, Doppler | 1 | 2021 | 269 | 0.05 | Why? |
| Incidence | 1 | 2021 | 25622 | 0.05 | Why? |
| Education, Distance | 1 | 2020 | 4956 | 0.05 | Why? |
| Cross Infection | 1 | 2021 | 8675 | 0.05 | Why? |
| Aorta | 1 | 2021 | 355 | 0.05 | Why? |
| Treatment Outcome | 3 | 2021 | 51732 | 0.04 | Why? |
| Biomarkers | 1 | 2020 | 23361 | 0.04 | Why? |
| Single-Blind Method | 1 | 2021 | 1283 | 0.04 | Why? |
| Drug Therapy, Combination | 2 | 2021 | 7268 | 0.04 | Why? |
| Surveys and Questionnaires | 2 | 2021 | 43792 | 0.04 | Why? |
| Clinical Deterioration | 1 | 2020 | 473 | 0.04 | Why? |
| Mouth | 1 | 2020 | 622 | 0.04 | Why? |
| Pulmonary Artery | 1 | 2021 | 803 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| Prognosis | 3 | 2021 | 32490 | 0.03 | Why? |
| Acinetobacter Infections | 1 | 2016 | 273 | 0.03 | Why? |
| Drug Synergism | 1 | 2016 | 833 | 0.03 | Why? |
| United States | 1 | 2020 | 46150 | 0.03 | Why? |
| Neoplasms | 1 | 2021 | 17251 | 0.03 | Why? |
| Oropharynx | 1 | 2020 | 1581 | 0.03 | Why? |
| Communicable Disease Control | 1 | 2020 | 29620 | 0.03 | Why? |
| Oxidative Stress | 1 | 2021 | 2050 | 0.02 | Why? |
| Age Factors | 2 | 2020 | 21039 | 0.02 | Why? |
| Severity of Illness Index | 3 | 2021 | 48226 | 0.02 | Why? |
| Recurrence | 1 | 2018 | 3675 | 0.02 | Why? |
| Drug Resistance, Multiple, Bacterial | 1 | 2016 | 1115 | 0.02 | Why? |
| Life Style | 1 | 2020 | 2708 | 0.02 | Why? |
| Echocardiography | 1 | 2021 | 3661 | 0.02 | Why? |
| Microbial Sensitivity Tests | 1 | 2016 | 2886 | 0.02 | Why? |
| Azithromycin | 1 | 2021 | 3943 | 0.02 | Why? |
| Polymerase Chain Reaction | 1 | 2021 | 6740 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2021 | 9537 | 0.02 | Why? |
| Tomography, X-Ray Computed | 2 | 2021 | 25144 | 0.02 | Why? |
| Saliva | 1 | 2020 | 4679 | 0.02 | Why? |
| Case-Control Studies | 1 | 2021 | 17671 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 13720 | 0.01 | Why? |
| Kidney Transplantation | 1 | 2020 | 5397 | 0.01 | Why? |
| Child, Preschool | 1 | 2020 | 36283 | 0.01 | Why? |
| Comorbidity | 1 | 2020 | 34796 | 0.01 | Why? |
| Anti-Bacterial Agents | 1 | 2016 | 10083 | 0.01 | Why? |
| Child | 1 | 2020 | 70012 | 0.01 | Why? |
Kayaaslan's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(106)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(100)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_